Ephraim E Parent (Ephraim Parent)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Systematic Review

Radical Prostatectomy

Positron Emission Tomography

Top Venues

Molecular cancer therapeutics

Journal of the Endocrine Society

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Adam M Kase, Justyna Joanna Gleba, James L Miller, Erin Miller, Joachim L Petit, Michael T Barrett, Yumei Zhou, Ephraim E Parent, Hancheng Cai, Joshua A Knight, Jacob J Orme, Jordan P Reynolds, William F Durham, Thomas M Metz, Nathalie Meurice, Brandy Edenfield, Aylin A Demirer, Ahmet Bilgili, Peyton G Hickman, Matthew L Pawlush, Laura Marlow, Daniel P Wickland, Winston Tan, John A Copland Iii
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer. Molecular cancer therapeutics 23 (6) (2024)
Adam M Kase, Justyna Joanna Gleba, James L Miller, Erin Miller, Joachim L Petit, Michael T Barrett, Yumei Zhou, Ephraim E Parent, Hancheng Cai, Joshua A Knight, Jacob J Orme, Jordan P Reynolds, William F Durham, Thomas M Metz, Nathalie Meurice, Brandy Edenfield, Aylin A Demirer, Ahmet Bilgili, Peyton G Hickman, Matthew L Pawlush, Laura Marlow, Daniel P Wickland, Winston Tan, John A Copland Iii
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer. Molecular cancer therapeutics 23 (6) (2024)
Adam M Kase, Justyna Joanna Gleba, James L Miller, Erin Miller, Joachim L Petit, Michael T Barrett, Yumei Zhou, Ephraim E Parent, Hancheng Cai, Joshua A Knight, Jacob J Orme, Jordan P Reynolds, William F Durham, Thomas M Metz, Nathalie Meurice, Brandy Edenfield, Aylin A Demirer, Ahmet Bilgili, Peyton G Hickman, Matthew L Pawlush, Laura Marlow, Daniel P Wickland, Winston Tan, John A Copland Iii
Patient-derived tumor xenograft study with CDK4/6 inhibitor plus AKT inhibitor for the management of metastatic castration-resistant prostate cancer. Molecular cancer therapeutics (2024)
Mehmet Asim Bilen, Akinyemi Akintayo, Yuan Liu, Olayinka Abiodun-Ojo, Omer Kucuk, Bradley C Carthon, David M Schuster, Ephraim E Parent
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [ 68 Ga]Ga DOTATATE PET-CT. Cancers 14 (24) (2022)
Adam M Kase, Winston Tan, John A Copland, Hancheng Cai, Ephraim E Parent, Ravi A Madan
The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer. Cancers 14 (6) (2022)
Ephraim E Parent, Amy M Fowler
Nuclear Receptor Imaging In Vivo-Clinical and Research Advances. Journal of the Endocrine Society 7 (3) (2022)
Ephraim E Parent, Adam M Kase
A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer. Cancers 14 (17) (2022)
Mehmet Asim Bilen, Akinyemi Akintayo, Yuan Liu, Olayinka Abiodun-Ojo, Omer Kucuk, Bradley C Carthon, David M Schuster, Ephraim E Parent
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [ 68 Ga]Ga DOTATATE PET-CT. Cancers 14 (24) (2022)
Ephraim E Parent, Amy M Fowler
Nuclear Receptor Imaging In Vivo-Clinical and Research Advances. Journal of the Endocrine Society 7 (3) (2022)
Mehmet Asim Bilen, Akinyemi Akintayo, Yuan Liu, Olayinka Abiodun-Ojo, Omer Kucuk, Bradley C Carthon, David M Schuster, Ephraim E Parent
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [ 68 Ga]Ga DOTATATE PET-CT. Cancers 14 (24) (2022)
Pooja Advani, Saranya Chumsri, Tanmayi Pai, Zhuo Li, Akash Sharma, Ephraim E Parent
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients. Annals of nuclear medicine 35 (11) (2021)
Ephraim E Parent
Letter regarding "18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review". Prostate cancer and prostatic diseases 24 (4) (2021)